Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 06, 2022 08:16 ET | Source: ReportLinker

Overactive Bladder Treatment Market Research Report by Drug Therapy, Disease Type, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

New York, May 06, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Overactive Bladder Treatment Market Research Report by Drug Therapy, Disease Type, Distribution,...
May 06, 2022 07:00 ET | Source: IGM Biosciences, Inc.

IGM Biosciences Announces Closing of Global Collaboration Agreement with Sanofi

MOUNTAIN VIEW, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies,...
May 06, 2022 06:51 ET | Source: ReportLinker

GLP-1 Receptor Agonist Market Research Report by Product, Drug Class, Route of Administration, Application, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

New York, May 06, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "GLP-1 Receptor Agonist Market Research Report by Product, Drug Class, Route of Administration,...
May 05, 2022 16:01 ET | Source: Denali Therapeutics Inc.

Denali Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to...
May 05, 2022 14:37 ET | Source: DiversityInc

DiversityInc Announces Top US Companies for Diversity at 2022 Top 50 Event

New York, NY, May 05, 2022 (GLOBE NEWSWIRE) -- DiversityInc, producers of the most prestigious corporate diversity, equity, and inclusion ranking for U.S. employers, announced the nation’s top...
May 05, 2022 08:00 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics to Share Novel Preclinical Findings Reinforcing the Advantage of IRAK4 Degraders over Kinase Inhibitors as well as First STAT3 Degrader Results in a Preclinical Model of Th17 Inflammation

-Data to be shared at the American Association of Immunologists (AAI) Annual Meeting -Results highlight potential for IRAK4 degraders to broadly impact TLR/IL-1R-driven inflammatory and autoimmune...
May 05, 2022 07:25 ET | Source: Allied Market Research

Global Insomnia Market Is Expected to Reach $6.3 Billion by 2030: Says AMR

Portland, OR, May 05, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Insomnia Market was estimated at $4.3 billion in 2020 and is expected to hit...
May 05, 2022 07:23 ET | Source: Research and Markets

Global Opioids Market Report to 2030 - Opportunity Analysis and Industry Forecasts

Dublin, May 05, 2022 (GLOBE NEWSWIRE) -- The "Opioids Market by Product Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
May 05, 2022 04:31 ET | Source: ReportLinker

Global Telecare Market Size, Share & Industry Trends Analysis Report By Product Type, By Regional Outlook and Forecast, 2021 - 2027

New York, May 05, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Telecare Market Size, Share & Industry Trends Analysis Report By Product Type, By Regional...
May 05, 2022 02:00 ET | Source: Immunicum AB

Immunicum AB: Immunicum Appoints Leopold Bertea as Chief Technology Officer

Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat established tumors, announced the appointment of Leopold...